AI assistant
Ascelia Pharma Major Shareholding Notification 2019
3132_iss_2019-05-02_74c168b0-4b36-406a-9b59-a71bccb8b876.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Ascelia Pharma AB
Holder
Sunstone Life Science Ventures II K/S
Instrument
Instrument Ordinary shares SE0010573113 Before the transaction Shares Data not given* Voting rights Data not given* Transaction Reason for major shareholding notification Other Date 29/04/2019 Limit for number of shares 15 % Limit for number of votes 15 % After the transaction Quantity Shares 4,497,699 Directly held voting rights 4,497,699 Indirectly held voting rights 0 Percentage Directly held shares 19.14818 % Directly held voting rights 19.14818 % Indirectly held voting rights 0 %
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 19.14818 % | 4,497,699 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 19.14818 % | 4,497,699 |
| Group total holdings |
||
| Voting rights 4,497,699 |
||
| Percentage of voting rights 19.14818 | ||
| Notes (other relevant informations according to law) | ||
| Flaggningen avser ändrad sammansättning av Sunstone Life Science Ventures II K/S position, |
till följd av att aktier som före Ascelia Pharma AB:s börsnotering utlånats för att underlätta övertilldelning i börsintroduktionserbjudandet återfåtts
Published
02/05/2019 10:47
Contact
| Name | Peter Benson, Merete Lundbye Møller | |
|---|---|---|
| Phone | +4520126000 | Email [email protected] |
*Source of information has chosen not to submit the data
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25